Capula Management LTD Protalix Bio Therapeutics, Inc. Transaction History
Capula Management LTD
- $17.1 Billion
- Q1 2025
A detailed history of Capula Management LTD transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Capula Management LTD holds 15,690 shares of PLX stock, worth $26,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,690Holding current value
$26,673% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.26MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$2.02 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny963KShares$1.64 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.46 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$1.16 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$1.05 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $84.6M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...